Literature DB >> 26941424

Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease.

Frank Lezoualc'h1, Loubina Fazal2, Marion Laudette2, Caroline Conte2.   

Abstract

cAMP is a universal second messenger that plays central roles in cardiovascular regulation influencing gene expression, cell morphology, and function. A crucial step toward a better understanding of cAMP signaling came 18 years ago with the discovery of the exchange protein directly activated by cAMP (EPAC). The 2 EPAC isoforms, EPAC1 and EPAC2, are guanine-nucleotide exchange factors for the Ras-like GTPases, Rap1 and Rap2, which they activate independently of the classical effector of cAMP, protein kinase A. With the development of EPAC pharmacological modulators, many reports in the literature have demonstrated the critical role of EPAC in the regulation of various cAMP-dependent cardiovascular functions, such as calcium handling and vascular tone. EPAC proteins are coupled to a multitude of effectors into distinct subcellular compartments because of their multidomain architecture. These novel cAMP sensors are not only at the crossroads of different physiological processes but also may represent attractive therapeutic targets for the treatment of several cardiovascular disorders, including cardiac arrhythmia and heart failure.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular disease; cyclic nucleotide; heart failure; remodeling; signaling pathways

Mesh:

Substances:

Year:  2016        PMID: 26941424     DOI: 10.1161/CIRCRESAHA.115.306529

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  60 in total

1.  Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis.

Authors:  Xi He; Aleksandra Drelich; Shangyi Yu; Qing Chang; Dejun Gong; Yixuan Zhou; Yue Qu; Yang Yuan; Zhengchen Su; Yuan Qiu; Shao-Jun Tang; Angelo Gaitas; Thomas Ksiazek; Zhiyun Xu; Jia Zhou; Zongdi Feng; Maki Wakamiya; Fanglin Lu; Bin Gong
Journal:  Life Sci       Date:  2019-02-07       Impact factor: 5.037

2.  Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol.

Authors:  Stefano Spolitu; Haruka Okamoto; Wen Dai; John A Zadroga; Erika S Wittchen; Jesper Gromada; Lale Ozcan
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

3.  Experimental Lung Injury Reduces Krüppel-like Factor 2 to Increase Endothelial Permeability via Regulation of RAPGEF3-Rac1 Signaling.

Authors:  Ru-Ting Huang; David Wu; Angelo Meliton; Myung-Jin Oh; Matthew Krause; Joyce A Lloyd; Recep Nigdelioglu; Robert B Hamanaka; Mukesh K Jain; Anna Birukova; John P Kress; Konstantin G Birukov; Gökhan M Mutlu; Yun Fang
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

4.  Extracellular adenosine-induced Rac1 activation in pulmonary endothelium: Molecular mechanisms and barrier-protective role.

Authors:  Anita Kovacs-Kasa; Kyung Mi Kim; Mary Cherian-Shaw; Stephen M Black; David J Fulton; Alexander D Verin
Journal:  J Cell Physiol       Date:  2018-03-07       Impact factor: 6.384

Review 5.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 6.  Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease.

Authors:  Maria Grazia Lampugnani; Elisabetta Dejana; Costanza Giampietro
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

7.  PDE4 and mAKAPβ are nodal organizers of β2-ARs nuclear PKA signalling in cardiac myocytes.

Authors:  Ibrahim Bedioune; Florence Lefebvre; Patrick Lechêne; Audrey Varin; Valérie Domergue; Michael S Kapiloff; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

8.  Estrogen deficiency compromised the β2AR-Gs/Gi coupling: implications for arrhythmia and cardiac injury.

Authors:  Hongjian Hou; Zhiwei Zhao; Jeremiah Ong'achwa Machuki; Lin Zhang; Yan Zhang; Lu Fu; Jinxia Wu; Yuyu Liu; Sian E Harding; Hong Sun
Journal:  Pflugers Arch       Date:  2018-01-02       Impact factor: 3.657

9.  Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.

Authors:  Toru Hashimoto; Grace E Kim; Richard S Tunin; Tolulope Adesiyun; Steven Hsu; Ryo Nakagawa; Guangshuo Zhu; Jennifer J O'Brien; Joseph P Hendrick; Robert E Davis; Wei Yao; David Beard; Helen R Hoxie; Lawrence P Wennogle; Dong I Lee; David A Kass
Journal:  Circulation       Date:  2018-10-30       Impact factor: 29.690

10.  Noradrenaline up-regulates volume-regulated chloride current by PKA-independent cAMP/exchange protein activated by cAMP pathway in human atrial myocytes.

Authors:  Guo-Sheng Xiao; Yan-Hui Zhang; Yan Wang; Hai-Ying Sun; Clive M Baumgarten; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.